Darzalex - Indicações| Janssen Medical Cloud

DARZALEX^® for multiple myeloma

Frontline transplant-eligible

.gbi-4182015-qGZDdCxRoQkwzi696B7Eht:before { opacity: 1; background-image: url(''https://eu-images.contentstack.com/v3/assets/blt193a365f63e4aaa2/bltca5ac1306ff28f7b/61b9c7ac6acea72b12eee8e8/replace_me_blue.png?width=423&height=118&format=png&quality=50''); }

Frontline transplant-ineligible

.gbi-4182015-6KrKarettrkH9W5HnLjS1K:before { opacity: 1; background-image: url(''https://eu-images.contentstack.com/v3/assets/blt193a365f63e4aaa2/bltca5ac1306ff28f7b/61b9c7ac6acea72b12eee8e8/replace_me_blue.png?width=423&height=118&format=png&quality=50''); }

.gbi-4182015-4YTAtUsK8hYsCNj7wTKdhw:before { opacity: 1; background-image: url(''https://eu-images.contentstack.com/v3/assets/blt193a365f63e4aaa2/bltca5ac1306ff28f7b/61b9c7ac6acea72b12eee8e8/replace_me_blue.png?width=423&height=118&format=png&quality=50''); }

From 2nd line

.gbi--1756384746-6j12uDRHmZ3iFq6e4LKaKx:before { opacity: 1; background-image: url(''https://eu-images.contentstack.com/v3/assets/blt193a365f63e4aaa2/blt7771ad0e62eae49b/61b9c97a8c873b37a7c6f47f/replace_me_pink.png?width=423&height=118&format=png&quality=50''); }

.gbi--1756384746-2QhMyQirdszuPntgjHwtRk:before { opacity: 1; background-image: url(''https://eu-images.contentstack.com/v3/assets/blt193a365f63e4aaa2/blt7771ad0e62eae49b/61b9c97a8c873b37a7c6f47f/replace_me_pink.png?width=423&height=118&format=png&quality=50''); }

From 3rd line

.gbi-1440090518-tthjc68BV7jiNf59kci7wA:before { opacity: 1; background-image: url(''https://eu-images.contentstack.com/v3/assets/blt193a365f63e4aaa2/blt955cef244eaac167/61b9cb7ce661952b180feb47/replace_me_grey.png?width=1300&height=118&format=png&quality=50''); }

DARZALEX^® for AL amyloidosis

Newly-diagnosed

.gbi-1440090518-rmNQwL9P1C1wGcr21tpxWe:before { opacity: 1; background-image: url(''https://eu-images.contentstack.com/v3/assets/blt193a365f63e4aaa2/blt955cef244eaac167/61b9cb7ce661952b180feb47/replace_me_grey.png?width=1300&height=118&format=png&quality=50''); }

Glossary

AL: amyloid light chain

IRR: infusion-related reaction

MM: multiple myeloma

Rd: lenalidomide, dexamethasone

VCd: Velcade^®, cyclophosphamide, dexamethasone

Vd: Velcade^®, dexamethasone

VMP: Velcade^®, melphalan, prednisone

VTd: Velcade^®, thalidomide, dexamethasone

Para visualizar o IECRCM de Darzalex, veja aqui.

CP-287814 - março 2022

Este site foi publicado pela Janssen-Cilag Farmacêutica, Lda. - que é a única responsável pelo seu conteúdo. Este site é dirigido a residentes em Portugal. Janssen-Cilag Farmacêutica, Lda. | Lagoas Park, Edifício 9, 2740-262 Porto Salvo | www.janssen.com/portugal |Sociedade por quotas | Matriculada na Conservatória do Registo Comercial de Oeiras, sob nº 10576 | Capital Social €2.693.508,64 | Nº Contribuinte 500 189 412

Aviso Legal Polìtica de Privacidade Política de Cookies

Definição de Cookies

Menu

DARZALEX® for multiple myeloma